Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Apr 01, 2021 2:47pm

225 Views

Post# 32924297

why no purchases on TSXV at 01 cent

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
14:11:51	A	0.05	0.01	5,000	85 Scotia	1 Anonymous	K
14:11:51	A	0.05	0.01	5,000	85 Scotia	1 Anonymous	K
13:55:17	U	0.045	0.005	9,000	33 Canaccord	9 BMO Nesbitt	K
13:55:17	U	0.045	0.005	1,000	2 RBC	9 BMO Nesbitt	K
13:55:17	U	0.045	0.005	10,000	13 Instinet	9 BMO Nesbitt	K
13:51:58	U	0.045	0.005	5,000	2 RBC	2 RBC	K
13:49:23	A	0.05	0.01	8,000	85 Scotia	1 Anonymous	K
13:44:49	U	0.045	0.005	20,000	13 Instinet	124 Questrade	K
13:36:14	H	0.05	0.01	10,000	79 CIBC	33 Canaccord	K
13:36:14	H	0.05	0.01	522	79 CIBC	7 TD Sec	E